Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

July 05, 2023Research Article

White Matter Hyperintensity Trajectories in Patients With Progressive and Stable Mild Cognitive Impairment

View ORCID ProfileFarooq Kamal, View ORCID ProfileCassandra Morrison, View ORCID ProfileJosefina Maranzano, View ORCID ProfileYashar Zeighami, View ORCID ProfileMahsa Dadar
First published July 5, 2023, DOI: https://doi.org/10.1212/WNL.0000000000207514
Farooq Kamal
1Department of Psychiatry, McGill University, Montreal, Quebec, Canada
2Douglas Mental Health University Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Farooq Kamal
  • For correspondence: farooq.kamal@mail.mcgill.ca
Cassandra Morrison
3Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
4McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cassandra Morrison
Josefina Maranzano
3Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
5Department of Anatomy, University of Quebec in Trois-Rivières, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Josefina Maranzano
Yashar Zeighami
1Department of Psychiatry, McGill University, Montreal, Quebec, Canada
2Douglas Mental Health University Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yashar Zeighami
Mahsa Dadar
1Department of Psychiatry, McGill University, Montreal, Quebec, Canada
2Douglas Mental Health University Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mahsa Dadar
Full PDF
Citation
White Matter Hyperintensity Trajectories in Patients With Progressive and Stable Mild Cognitive Impairment
Farooq Kamal, Cassandra Morrison, Josefina Maranzano, Yashar Zeighami, Mahsa Dadar
Neurology Jul 2023, 10.1212/WNL.0000000000207514; DOI: 10.1212/WNL.0000000000207514

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
32

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Background and Objectives: White matter hyperintensities are pathological brain changes that are associated with increased age and cognitive decline. However, the association of white matter hyperintensity burden with amyloid positivity and conversion to dementia in people with mild cognitive impairment (MCI) is unclear. The aim of the current study was to expand on this research by examining whether change in white matter hyperintensity burden over time differs in amyloid-negative (Aβ-) and amyloid-positive (Aβ+) people with MCI who either remain stable or convert to dementia. To examine this question, we compared regional white matter hyperintensity burden in four groups: amyloid positive (Aβ+) progressor, amyloid negative (Aβ–) progressor, amyloid positive (Aβ+) stable, and amyloid negative (Aβ–) stable.

Methods: Participants with MCI from the Alzheimer’s Disease Neuroimaging Initiative were included if they had APOE ɛ4 status and if amyloid measures were available to determine amyloid status (i.e., amyloid positive, or amyloid negative). Participants with a baseline diagnosis of MCI, had APOE ɛ4 information and amyloid measures were included. An average of 5.7 follow-up timepoints per participant were included, with a total of 5054 follow-up timepoints with a maximum follow-up duration of 13 years. Differences in total and regional white matter hyperintensity burden were examined using linear mixed-effects models.

Results: A total of 820 participants (55-90 years of age) were included in the study (Aß+ Progressor, n= 239; Aß– Progressor, n= 22; Aß+ Stable, n= 343; Aß– Stable, n= 216). People who were Aß– stable exhibited reduced baseline white matter hyperintensities compared to Aß+ progressors and Aß+ stable at all regions of interest (β belongs to [.20 –.33], CI belongs to [.03 –.49], p<.02), except Deep white matter hyperintensities. When examining longitudinal results, compared to Aß– stable, all groups had steeper accumulation in white matter hyperintensity burden with Aß+ progressors (β belongs to [-.03–.06], CI belongs to [-.05–.09], p<.01) having the largest increase (i.e., largest increase in white matter hyperintensity accumulation over time).

Discussion: These results indicate that white matter hyperintensity accumulation contributes to conversion to dementia in older adults with mild cognitive impairment who are amyloid-positive and negative people.

Keywords,
  • Received December 22, 2022.
  • Accepted in final form April 25, 2023.
  • © 2023 American Academy of Neurology

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Costs and Utilization of New-to-Market Neurologic Medications

Dr. Robert J. Fox and Dr. Mandy Leonard

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Alzheimer's disease
  • MRI
  • Cognitive aging
  • Assessment of cognitive disorders/dementia
  • MCI (mild cognitive impairment)

Alert Me

  • Alert me when eletters are published
Neurology: 101 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise